These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6228936)

  • 1. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract].
    Gerhardt G; Rogalla K; Jaeger J
    Fortschr Med; 1990 Jun; 108(19):384-8. PubMed ID: 2199358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
    Lazzari R; Passeri M; Chierichetti SM
    Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
    Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
    G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
    [No Abstract]   [Full Text] [Related]  

  • 6. Deapril-ST for senile dementia.
    Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
    Bagatin J; Rumboldt Z; Jurisić M; Vujić D
    Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical assessment of brain failure in the elderly.
    McConnachie RW
    Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
    Slánská J
    Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
    Ronge J; Dennler HJ
    Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
    Muchnik S
    Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
    Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
    J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
    Matejcek M; Knor K; Piguet PV; Weil C
    J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
    Yesavage JA; Hollister LE; Burian E
    J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
    Guiraud-Chaumeil B
    Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
    Dennler HJ; Bachmann H
    MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.